APA (7th ed.) Citation

A, M., KA, C., J, B., RB, P., DA, R., GM, B., & RH, B. (1998). Exemplifying guidelines for preparation of recombinant DNA products in phase I trials in cancer: Preparation of a genetically engineered anti-CEA single chain Fv antibody. European journal of cancer (Oxford, England : 1990), 34(7), 968. https://doi.org/10.1016/s0959-8049(98)00035-5

Chicago Style (17th ed.) Citation

A, Mayer, Chester KA, Bhatia J, Pedley RB, Read DA, Boxer GM, and Begent RH. "Exemplifying Guidelines for Preparation of Recombinant DNA Products in Phase I Trials in Cancer: Preparation of a Genetically Engineered Anti-CEA Single Chain Fv Antibody." European Journal of Cancer (Oxford, England : 1990) 34, no. 7 (1998): 968. https://doi.org/10.1016/s0959-8049(98)00035-5.

MLA (9th ed.) Citation

A, Mayer, et al. "Exemplifying Guidelines for Preparation of Recombinant DNA Products in Phase I Trials in Cancer: Preparation of a Genetically Engineered Anti-CEA Single Chain Fv Antibody." European Journal of Cancer (Oxford, England : 1990), vol. 34, no. 7, 1998, p. 968, https://doi.org/10.1016/s0959-8049(98)00035-5.